comparemela.com

Latest Breaking News On - கண் ஆராய்ச்சி ஆஸ்திரேலியா - Page 3 : comparemela.com

New light on glaucoma gene discoveries

Photo Shutterstock Globally 78 million people have glaucoma. That is every one in 200 people aged 40, which rises to one in eight by age 80. Most people with glaucoma are not aware of it as most glaucoma patients have zero symptoms. Catch the disease early and you have a great chance of preserving your vision for the years to come. Ahead of World Glaucoma Week (7-13 March 2021, #glaucomaweek), Australian researchers published the largest genetic study of glaucoma identifying 44 new genetic variants that may lead to new treatment targets. Ten Australian institutions involving some of the country’s most prominent glaucoma researchers – including Matthew Flinders Distinguished Professor Jamie Craig and Flinders University colleagues with the Australian and New Zealand Registry of Advanced Glaucoma (ANZRAG) consortium – were involved in the international effort which analysed genes in more than 34,000 people with glaucoma across multiple ancestries for the first time.

Bionic Vision Technologies Advances Clinical Program With AU$1 million Medical Research Future Fund Grant

Bionic Vision Technologies Advances Clinical Program With AU$1 million Medical Research Future Fund Grant News provided by Share this article Share this article MELBOURNE, Australia, Feb. 16, 2021 /PRNewswire/ Bionic Vision Technologies (BVT) has started work on the next phase of development for its world-leading Australian bionic eye technology thanks to a recent Australian Government grant to refine its vision processing algorithms. BVT s bionic eye is designed for people with the inherited retinal disease retinitis pigmentosa for which there is no current cure. Clinical study data from patients implanted with the device show the prosthesis is safe and gives significant improvements to functional vision and quality of life. Users reported an improved awareness of external objects and surroundings.

Thomson X Inks Strategic Partnership with Singapore-Based Startup Plano and Set Sights on Managing Myopia in Asia

TX ), a wholly-owned subsidiary of SGX Mainboard-listed Thomson Medical Group Limited (the Group ), today announced a strategic partnership with Plano Pte Ltd ( Plano ), a Singapore-based HealthTech startup. The collaboration will leverage on the respective strengths of TX and Plano to address and manage the rapidly increasing incidence of myopia through innovative technological solutions. Myopia is steadily growing into one of the biggest public health challenges in the world, affecting an estimated 2.6 billion people globally, or about one-third of the world s population. By 2050, myopia is projected to affect 5 billion people, which is estimated to be about half of the world s population

We don t expect newborns to have cataracts, but looking for warning signs can save a child s sight

1 / of 2 We don t expect newborns to have cataracts, but looking for warning signs can save a child s sight TueTuesday 22 DecDecember 2020 at 6:57pm Hamish was diagnosed with cataracts by chance after passing several standard wellness checks after he was born. ( Print text only Cancel Hunter was just three weeks old when he had his first surgery. The second was three weeks later. Key points: One in 4,500 children are believed to be affected by cataracts but there is not enough modern data to be sure Cataracts Kids Australia is encouraging parents to look for warning signs because the condition can be difficult to diagnose

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.